Skip to content

Prognostic Potential of Prehospital Biomarkers in TBI Patients

Prognostic Potential of Prehospital S100B, Glial Fibrillary Acidic Protein (GFAP) and Neuron Specific Annuals (NSE) Levels in Patients Suffering Severe Traumatic Brain Injury (TBI)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03062566
Acronym
PreTBI III
Enrollment
6
Registered
2017-02-23
Start date
2017-02-15
Completion date
2019-02-01
Last updated
2019-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brain INjury

Keywords

biomarkers, point-of-care analysis

Brief summary

The PreTBI III study aims to investigate the prognostic potential of prehospital and repeated in-hospital S100B, NSE and GFAP measurements as predictors of neurological outcome in patients suffering severe TBI. Knowledge on prehospital S100B, GFAP and NSE levels as predictors of neurological outcome and mortality may underline the potential of a point-of-care analysis. Possibly, the early biomarker levels may contributed to accurate monitoring of biomarker dynamics and hereby support neurosurgeons and anaesthetists in the clinical decision-making regarding treatment and level of care offered to the patient. Hypotheses: 1. Prehospital S100B level is a significant predictor of unfavourable neurological outcome (dichotomized disability rating scale (DRS) and glasgow outcome scale extended (GOS-E) measures) in severe TBI patients. 2. Prehospital GFAP level is a significant predictor of unfavourable neurological outcome (dichotomized DRS and GOSE measures) in severe TBI patients. 3. Prehospital NSE level is a significant predictor of unfavourable neurological outcome (dichotomized DRS and GOSE measures) in severe TBI patients. 4. combined panel of prehospital S100B, GFAP and NSE levels is a significant predictor of unfavourable neurological outcome (dichotomized DRS and GOSE measures) in severe TBI patients. 5. Unfavourable neurological outcome (dichotomized DRS and GOSE measures) in severe TBI patients can be predicted by dynamics in repeated measurements of S100B, GFAP and NSE.

Interventions

OTHERBlood sampling

Blood sampling from peripheral venous catheter routinely inserted in trauma patients during transportation

Sponsors

Central Denmark Region
CollaboratorOTHER
Aarhus University Hospital
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patients presenting with Glasgow Coma Score (GCS) GCS 3-8 suffering relevant trauma and displaying relevant clinical indices compatible with TBI as evaluated by EMS staff. Patients are considered incompetent due to on-going alteration of mental state.

Exclusion criteria

* \>6 hours elapsed after trauma, unknown time of trauma, multi trauma, known dementia, chronic psychosis or active central nervous system (CNS) pathology.

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity of se-S100B in relation to a binary outcome measured by by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 yearNeurological outcome will be evaluated by a dichotomized glasgow outcome score extended (GOSE) as Favorable (GOSE 5-8)/Unfavorable (GOSE 1-4)
Negative predictive value of se-S100B in relation to a binary outcome measured by by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 yearNeurological outcome will be evaluated by a dichotomized glasgow outcome score extended (GOSE) as Favorable (GOSE 5-8)/Unfavorable (GOSE 1-4)
Positive predictive value of se-S100B in relation to a binary outcome measured by by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 yearNeurological outcome will be evaluated by a dichotomized glasgow outcome score extended (GOSE) as Favorable (GOSE 5-8)/Unfavorable (GOSE 1-4)
Specificity of se-S100B in relation to a binary outcome measured by by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 yearNeurological outcome will be evaluated by a dichotomized glasgow outcome score extended (GOSE) as Favorable (GOSE 5-8)/Unfavorable (GOSE 1-4)

Secondary

MeasureTime frameDescription
Specificity of se-NSE in relation to a binary outcome measured by by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 year of traumaNeurological outcome will be evaluated by a dichotomized glasgow outcome score extended (GOSE) as Favorable (GOSE 5-8)/Unfavorable (GOSE 1-4)
Sensitivity of se-GFAP in relation to a binary outcome measured by by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 yearNeurological outcome will be evaluated by a dichotomized glasgow outcome score extended (GOSE) as Favorable (GOSE 5-8)/Unfavorable (GOSE 1-4)
Specificity of se-GFAP in relation to a binary outcome measured by by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 year of traumaNeurological outcome will be evaluated by a dichotomized glasgow outcome score extended (GOSE) as Favorable (GOSE 5-8)/Unfavorable (GOSE 1-4)
Positive predictive value of se-GFAP in relation to a binary outcome measured by by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 year of traumaNeurological outcome will be evaluated by a dichotomized glasgow outcome score extended (GOSE) as Favorable (GOSE 5-8)/Unfavorable (GOSE 1-4)
Negative predictive value of se-GFAP in relation to a binary outcome measured by by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 year of traumaNeurological outcome will be evaluated by a dichotomized glasgow outcome score extended (GOSE) as Favorable (GOSE 5-8)/Unfavorable (GOSE 1-4)
Sensitivity of se-NSE in relation to a binary outcome measured by by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 year of traumaNeurological outcome will be evaluated by a dichotomized glasgow outcome score extended (GOSE) as Favorable (GOSE 5-8)/Unfavorable (GOSE 1-4)
Positive predictive value of se-NSE in relation to a binary outcome measured by by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 year of traumaNeurological outcome will be evaluated by a dichotomized glasgow outcome score extended (GOSE) as Favorable (GOSE 5-8)/Unfavorable (GOSE 1-4)
Negative predictive value of se-NSE in relation to a binary outcome measured by by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 year of traumaNeurological outcome will be evaluated by a dichotomized glasgow outcome score extended (GOSE) as Favorable (GOSE 5-8)/Unfavorable (GOSE 1-4)

Other

MeasureTime frameDescription
Sensitivity of combined se-S100B, se-GFAP and se-NSE in relation to a binary outcome measured by by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 year of trauma
Mortality rates corresponding to se-NSE valuesin relation to event within 1 year of traumasurvival versus death \<7 days, 3 months and 6 months after trauma 6-month
Mortality rates corresponding to se-GFAP valuesin relation to event within 1 year of traumasurvival versus death \<7 days, 3 months and 6 months after trauma 6-month
Specificity of combined se-S100B, se-GFAP and se-NSE in relation to a binary outcome measured by by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 year of trauma
Positive predictive value of combined se-S100B, se-GFAP and se-NSE in relation to a binary outcome measured by by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 year of trauma
Negative predictive value of combined se-S100B, se-GFAP and se-NSE in relation to a binary outcome measured by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 year of trauma
Biomarker dynamics between prehospital and in-hospital se-S100B values in relation to a binary outcome measured by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 year of trauma
Biomarker dynamics between prehospital and in-hospital se-GFAP values in relation to a binary outcome measured by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 year of trauma
Biomarker dynamics between prehospital and in-hospital se-NSE values in relation to a binary outcome measured by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 year of trauma
Biomarker dynamics between prehospital and in-hospital combination of se-S100B, se-GFAP and se-NSE values in relation to a binary outcome measured by a yes/no question of favorable neurological outcome pick favorable/unfavorablein relation to event within 1 year of trauma
Mortality rates corresponding to se-S100B valuesin relation to event within 1 year of traumasurvival versus death \<7 days, 3 months and 6 months after trauma 6-month

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026